Source and scope
This summary is bounded to the recommendations, population and decisions covered by 2021 Guideline update: Diagnosis and management of asthma in preschoolers, children and adults. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CTS asthma 2021
Source-attributed clinical priorities
- Confirm variable expiratory airflow limitation with objective testing whenever feasible; do not diagnose asthma from symptoms alone.
- Use an inhaled-corticosteroid-containing strategy rather than short-acting bronchodilator monotherapy for ongoing asthma care.
- Before stepping up, reassess diagnosis, inhaler technique, adherence, exposures, comorbidity and exacerbation risk.
- Give every patient self-management education and a written action plan.
sources for this section:CTS asthma 2021
Practical assessment and management workflow
1
Record daytime and night symptoms, reliever use, activity limitation, lung function and exacerbations.
2
Verify spirometric variability or another accepted objective demonstration when the patient is stable.
3
Select an inhaled-corticosteroid-containing step from the CTS age and risk pathway.
4
Recheck control, exacerbation risk, technique and adherence before stepping up or down.
sources for this section:CTS asthma 2021
Safety, red flags and urgent escalation
- Treat marked breathlessness, hypoxemia, exhaustion or a silent chest as an acute severe attack.
- Do not let a normal examination between episodes override objective diagnostic testing.
- Review oral-corticosteroid exposure and refer recurrent exacerbations or persistently uncontrolled disease.
sources for this section:CTS asthma 2021
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CTS asthma 2021
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CTS asthma 2021
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Thoracic Society2021 Guideline update: Diagnosis and management of asthma in preschoolers, children and adultsaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.